Cobimetinib

Cobimetinib

Cobimetinib (GDC-0973, RG7420) is a potent, selective, and orally available MEK1 inhibitor (IC50 = 4.2 nM) with high kinase selectivity. It induces differentiation and apoptosis in cancer cells and enhances efficacy in combination therapies. Reagent grade, for research use only.

Molecular structure of the compound BP-43634
    • Unit
    • Price
    • Qty
    • 25 MG
    • $110.00
    • 50 MG
    • $190.00
    • 100 MG
    • $320.00

Usually ships within 24 hours.

Would you like to inquire about custom quantity?
Inquire